Results 51 to 60 of about 17,990 (185)
Archives of Public Health, 2023 Background Ethiopia is one of the top 10 countries in the world where 90% visceral leishmaniasis cases are reported. Metema-Humera lowlands are the most important foci in Ethiopia. Blood transfusion in visceral leishmaniasis endemic foci in Ethiopia does
Iyasu Melkie +3 more
doaj +1 more source
The State of Public Health in Somalia: Top 5 Challenges and Strategies for Improvement
Public Health Challenges, Volume 4, Issue 4, December 2025.Somalia's public health system is severely strained by five interconnected challenges: inadequate WASH infrastructure, widespread malnutrition and food insecurity, high burden of infectious diseases, critical gaps in maternal and child health, and the rising prevalence of noncommunicable diseases (NCDs).
Yusuf Hared Abdi +4 more
wiley +1 more source
Journal of Zoonotic Diseases, 2023 The disease Leishmaniasis is a neglected illness with two major forms clinically including cutaneous leishmaniasis and visceral leishmaniasis. From almost 100 endemic countries, an estimated one million additional records of leishmaniasis each year are
Basim Saleem Ahmed Al Sulivany +1 more
doaj +1 more source
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Hoda Haghshenas +3 more
wiley +1 more source
Health Science Reports, Volume 8, Issue 10, October 2025.ABSTRACT Background/Aim Cutaneous leishmaniasis (CL) is a protozoan disease transmitted by sandflies, causing skin lesions and scars. In Pakistan, the Hazara community in Balochistan is significantly affected, with over 400,000 cases reported in 2016.
Zahra Ali +7 more
wiley +1 more source
HIV-associated visceral leishmaniasis [PDF]
Clinical Microbiology and Infection, 2001 Visceral leishmaniasis (VL) is a severe disease caused by protozoa of the genus Leishmania that usually affects immunocompetent hosts in endemic areas [1,2]. Since the mid-1980s, VL has been recognized as an opportunistic infection associated with some immunodeficiency states, such as neoplasms, organ transplantation, or treatment with ...
Vicente Pintado, R. López-Vélez
openaire +3 more sources
Brazilian Journal of Infectious Diseases, 2019 Visceral leishmaniasis is a serious and debilitating infection with high fatality rate in tropical and subtropical countries. As clinical symptoms of visceral leishmaniasis are not so specific, confirmatory diagnostic methods with high sensitivity and ...
Gilberto Silva Nunes Bezerra +4 more
doaj +1 more source
A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery
BMC Infectious Diseases, 2023 Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that occurs 2–3 years after an apparently successful treatment of visceral leishmaniasis (VL).
Md. Mehedi Hasan +6 more
doaj +1 more source
The Effectiveness of Dengue Vector Control: A Meta‐Review
Tropical Medicine &International Health, Volume 30, Issue 10, Page 1069-1086, October 2025.ABSTRACT Background Dengue vector control plays an important role in reducing the burden of dengue infection. This study aimed to summarise the evidence of published systematic reviews on the efficacy of dengue vector control interventions. Methods Systematic reviews of cluster randomised controlled trials and randomised controlled trials in ...
Gary K. K. Low +4 more
wiley +1 more source
Leishmaniasis–HIV coinfection: current challenges
HIV/AIDS: Research and Palliative Care, 2016 José Angelo Lauletta Lindoso,1,2 Mirella Alves Cunha,3 Igor Thiago Queiroz,4 Carlos Henrique Valente Moreira2 1Laboratory of Soroepidemiology (LIM HC-FMUSP), São Paulo University, São Paulo, 2Instituto de Infectologia Emilio ...
Lindoso JAL +3 more
doaj